Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center (BIDMC). He is also the Section Head of Interventional Cardiology and Vascular Research at the Smith Center for Outcomes Research iand an Associate Professor of Medicine at Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures. Dr. Secemsky leads the interventional cardiology and vascular research program at the Smith Center. Dr. Secemsky’s research program is funded by the National Institutes of Health (NIH), Harvard Medical School, extramural grants and philanthropy.
Disclosure(s): Abbott, Asahi, BD, Boston Scientific, Conavi, Cook, Cordis, Endovascular Engineering, Evident Vascular, Gore, InfraRedx, Medtronic, Penumbra, Philips, RapidAI, Rampart IC, R3, Regeneron, Shockwave, Siemens, SoniVie, Teleflex, Terumo, Thrombolex, Vent: Consulting Fees (e.g., advisory boards) (Ongoing)
Saturday, March 7, 2026
10:56 AM - 11:04 AM EST
Panel Discussion | Radiation Protection - Call for Action
Saturday, March 7, 2026
11:52 AM - 12:10 PM EST
Future Directions for RDN | From Hypertension to AFib and Beyond
Sunday, March 8, 2026
10:30 AM - 10:38 AM EST
Case-in-a-Box | Symplicity Spyral™ RF RDN System
Sunday, March 8, 2026
11:18 AM - 11:48 AM EST
Sunday, March 8, 2026
12:30 PM - 12:32 PM EST
Overview of the Unmet Need in Hypertension and the Symplicity Spyral System
Sunday, March 8, 2026
12:32 PM - 12:47 PM EST
Sunday, March 8, 2026
12:52 PM - 12:59 PM EST
Practicalities of HTN Programs
Sunday, March 8, 2026
1:05 PM - 1:09 PM EST
Sunday, March 8, 2026
1:09 PM - 1:16 PM EST
Sunday, March 8, 2026
1:22 PM - 1:30 PM EST
Intravascular Lithotripsy in Below the Knee Disease: 30-Day Outcomes From the Disrupt BTK II Study
Monday, March 9, 2026
9:04 AM - 9:12 AM EST
New Scaffolds and Stents for Tibial Disease
Monday, March 9, 2026
11:28 AM - 11:36 AM EST
Panel Discussion | Optimal Devices for the Treatment of CLI
Monday, March 9, 2026
12:08 PM - 12:30 PM EST
Renal Denervation: How are We Doing 2-Years Post FDA Approval?
Monday, March 9, 2026
10:10 AM - 10:20 AM EST